The pharmaceutical supply chain is a confusing maze that is impenetrable when it comes to understanding how drug prices are determined. State policies that set reporting requirements for various participants in this complex system can provide insight into what is needed to develop policies in Missouri that would rein in costs.
The third brief in our series, “Drug Pricing Transparency,” discusses how legislation in other states is reducing drug prices. Learning from other states serves as a critical step in ensuring Missourians can afford the medications they need.